FORMULATION DEVELOPMENT AND EVALUATION OF SUSTAINED RELEASE GASTRORETENTIVE TABLET OF EMTRICITABINE

G. V. RADHA; K. TRIDEVA SASTRI; N. MANASWIN; B. LIKHITHA

doi:10.22159/ijap.2019v11i5.34840

Authors

G. V. RADHA GITAM Institute of Pharmacy, GITAM Deemed to be University, Rushikonda, Visakhapatnam, Andhra Pradesh State, India
K. TRIDEVA SASTRI GITAM Institute of Pharmacy, GITAM Deemed to be University, Rushikonda, Visakhapatnam, Andhra Pradesh State, India
N. MANASWIN GITAM Institute of Pharmacy, GITAM Deemed to be University, Rushikonda, Visakhapatnam, Andhra Pradesh State, India
B. LIKHITHA GITAM Institute of Pharmacy, GITAM Deemed to be University, Rushikonda, Visakhapatnam, Andhra Pradesh State, India

DOI:

https://doi.org/10.22159/ijap.2019v11i5.34840

Keywords:

Emtricitabine, Sustained release, Gastro retention, HPMC k4m, Ethyl cellulose

Abstract

Objective: The study aims for the design and evaluation of floating tablets of emtricitabine (EMT), post oral administration to sustain the release and enhance gastric residence time (GRT).

Methods: EMT is a nucleoside reverse-transcriptase inhibitor for the prevention and treatment of human immunodeficiency virus (HIV) infection. The investigation was considered to formulate a floating tablet of EMT with various agents. The formulation included with various concentrations of hydroxypropyl methylcellulose (HPMC) k4m, ethylcellulose, microcrystalline cellulose, polyvinylpyrrolidone (PVP) by wet granulation method. Various parameters for the prepared formulations were evaluated for weight variation, thickness, hardness, friability, floating lag time (FLT), total floating time (TFT), swelling index, in vitro drug release, and fourier-transform infrared spectroscopy (FTIR) studies.

Results: The best formulation F1 exhibited 88.28% release in 24 h duration, with a floating lag time of 7 min and swelling index of 52.1% and drug content was determined to be 98.27%. The release mechanism was determined to be first order with higuchi release kinetics displaying diffusion along with the dissolution of the EMT from the tablet by non fickian mechanism.

Conclusion: EMT tablets showed an increased GRT with a sustained release for 24 h thereby allowing a better window for absorption consequently improve the therapeutic effect of the drug.

Downloads

Download data is not yet available.

References

Yeole PG, S Khan, VF Patel. Floating drug delivery system: need and development. Indian J Pharm Sci 2005;67:265-72.

Hirtz J. The GIT absorption of drugs in man: a review of current concepts and methods of investigation. Br J Clin Pharmacol 1985;19:77S-83S.

Streubel A, Siepmann J, Bodmeier R. Drug delivery to the upper small intestine window using gastro retentive technologies. Curr Opin Pharmacol 2006;6:501-8.

HP Shah, ST Prajapati, CN Patel. Gastro retentive drug delivery systems: from conception to commercial success. J Crit Rev 2017;4:10-21.

Huldrych F Gunthard, Michael S Saag, Constance A Benson, Carlos del Rio, Joseph J Eron, Joel E Gallant, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults. JAMA 2016;316:191-210.

Eric J Arts, Daria J Hazuda. HIV-1 antiretroviral drug therapy. Cold Spring Harb Perspect Med 2012;2:1-23.

MA Mozaini, T Alrahbeni, R Al-Mograbi, A Alrajhi. Antiretroviral resistance in HIV-1 patients at a tertiary medical institution in Saudi Arabia: a retrospective study and analysis. BMC Infect Dis 2018;18:2-10.

S Daisy CK, S Vengatesh, K Elango, RD Damayanthi, N Deattu, P Christina. Formulation and evaluation of floating tablets of ondansetron hydrochloride. Int J Drug Dev Res 2012;4:265-74.

Swati C Jagdale, Somnath, A Patil, Bhanudas, S Kuchekar. Design, development and evaluation of floating tablets of tapentadol hydrochloride using chitosan. Asian J Pharm Clin Res 2012;5:163-8.

AA Kharia, SN Hiremath, AK Singhai, LK Omray, SK Jain. Design and optimization of floating drug delivery system of acyclovir. Indian J Pharma Sci 2010;72:599–606.

BW Tekade, UT Jadhao, SG Patil, VR Patil. Formulation and in vitro evaluation of floating tablets of cefpodoxime proxetil. Int J Curr Pharm Res 2017;9:18-22.

J Padmavathy, D Saravanan, D Rajesh. Formulation and evaluation of ofloxacin floating tablets using HPMC. Int J Pharm Pharm Sci 2011;3:170–3.

Albadry AA, WK Ali, FA Al-Saady. Formulation and evaluation of prochlorperazine maleate sustained floating release tablet. Int J Pharm Pharm Sci 2017;9:89-98.

Aniruddha MR, Joseph BS. Use of a moist granulation technique (MGT) to develop controlled-release dosage forms of acetaminophen. Drug Dev Ind Pharm 2001;27:337-44.

S Anepu, L Duppala, Soma SM. Formulation development, characterization, and in vitro evaluation of floating matrix dosage form of tramadol hydrochloride using various polymers. Asian J Pharm Clin Res 2017;10:281-90.

Sharma VK. Meloxicam loaded floating sustained release matrix tablet. J Adv Pharm Edu Res 2012;2:18-24.

Asnaashari S, Khoei NS, Zarrintan MH, Adibkia K, Javadzadeh Y. Preparation and evaluation of novel metronidazole sustained release and floating matrix tablets. Pharm Dev Technol 2011;16:400-7.

V Yadav, P Jadhav, P Salunkhe, P Nikam, S Matkar. Formulation and evaluation of gastroretentive tablets of antiulcer drug. Asian J Pharm Clin Res 2016;9:48-52.

Yadav KS, Satish CS, Shivkumar HG. Preparation and evaluation of chitosan-poly (Acrylic acid) hydrogel as stomach specific delivery for amoxicillin and metronidazol. Indian J Pharm Sci 2007;69:91-5.

Albadry WK Ali, FA Al-Saady. Formulation and evaluation of prochlorperazine maleate sustained floating release tablet. Int J Pharm Pharm Sci 2017;9:89-98.

D Mali, RS Bathe. Development and evaluation of gastroretentive floating tablets of a quinapril HCl by direct compression technique. Int J Pharm Pharm Sci 2017;9:35-46.

K Babu, MV Ramana. Development and in vivo evaluation of gastro retentive floating tablets of antipsychotic drug risperidone. Int J Pharm Pharm Sci 2016;11:43-52.